Skip to main content
Log in

CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Cullin 4A (CUL4A) encodes a core subunit of an E3 ubiquitin ligase that targets proteins for ubiquitin-mediated degradation, and aberrant expression of the CUL4A is found in many tumor types. However, its roles and clinicopathologic significance in pituitary adenomas are not clear. The aim of this study was to investigate the possible role of CUL4A in pituitary tumorigenesis. Immunohistochemistry was used to examine CUL4A expression in human normal pituitaries and pituitary tumors with respect to various clinicopathologic factors in pituitary adenomas. Cell proliferation was assessed by MTT and colony formation, and migration and invasion were analyzed by Transwell and Matrigel assays after CUL4A overexpression or knockdown in pituitary tumor cells. Overexpression of CUL4A was frequently observed in pituitary adenomas compared with normal adenohypophysial tissue and significantly associated with tumor progressiveness and invasion. CUL4A overexpression in GH3 adenoma cells increased colony numbers, cell viability and cell invasion and silencing CUL4A in AtT20 adenoma cells decreased cell proliferation, migration and invasion. Mechanistically, CUL4A could modulate the expression of p53, p21, and p27 in pituitary tumor cells. In addition, high levels of CUL4A expression also significantly inversely correlated with the p53 protein level in human pituitary adenomas. Our results indicate that CUL4A enhances pituitary cell proliferation, migration and invasion and may thus contribute to pituitary tumor development and progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Shiyanov P, Nag A, Raychaudhuri P (1999) Cullin 4A associates with the UV-damaged DNA-binding protein DDB. J Biol Chem 274:35309–35312

    Article  CAS  PubMed  Google Scholar 

  2. He YJ, McCall CM, Hu J, Zeng Y, Xiong Y (2006) DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases. Genes Dev 20:2949–2954

    Article  CAS  PubMed  Google Scholar 

  3. Chen LC, Manjeshwar S, Lu Y, Moore D, Ljung BM, Kuo WL, Dairkee SH, Wernick M, Collins C, Smith HS (1998) The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res 58:3677–3683

    CAS  PubMed  Google Scholar 

  4. Shinomiya T, Mori T, Ariyama Y, Sakabe T, Fukuda Y, Murakami Y, Nakamura Y, Inazawa J (1999) Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon. Genes Chromosomes Cancer 24:337–344

    Article  CAS  PubMed  Google Scholar 

  5. Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, Lichter P (2000) Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer 28:145–152

    Article  CAS  PubMed  Google Scholar 

  6. Michiels EM, Weiss MM, Hoovers JM, Baak JP, Voute PA, Baas F, Hermsen MA (2002) Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization. J Pediatr Hematol Oncol 24:205–210

    Article  PubMed  Google Scholar 

  7. Yasui K, Arii S, Zhao C, Imoto I, Ueda M, Nagai H, Emi M, Inazawa J (2002) TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology 35:1476–1484

    Article  CAS  PubMed  Google Scholar 

  8. Hung MS, Mao JH, Xu Z, Yang CT, Yu JS, Harvard C, Lin YC, Bravo DT, Jablons DM, You L (2011) Cul4A is an oncogene in malignant pleural mesothelioma. J Cell Mol Med 15:350–358

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Birner P, Schoppmann A, Schindl M, Dinhof C, Jesch B, Berghoff AS, Schoppmann SF (2012) Human homologue for Caenorhabditis elegans CUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinoma. J Clin Pathol 65:507–511

    Article  PubMed  Google Scholar 

  10. Marko NF, Weil RJ (2012) Pituitary gland: new pathways in the pathogenesis of pituitary adenomas. Nat Rev Endocrinol 8:572–573

    Article  CAS  PubMed  Google Scholar 

  11. Sharif-Alhoseini M, Rahimi-Movaghar V (2012) Pituitary adenomas: a review. J Inj Violence Res 4(3 Suppl 1):56

    Google Scholar 

  12. Righi A, Agati P, Sisto A, Frank G, Faustini-Fustini M, Agati R, Mazzatenta D, Farnedi A, Menetti F, Marucci G, Foschini MP (2012) A classification tree approach for pituitary adenomas. Hum Pathol 43:1627–1637

    Article  CAS  PubMed  Google Scholar 

  13. Pratheesh R, Rajaratnam S, Prabhu K, Mani SE, Chacko G, Chacko AG (2012) The current role of transcranial surgery in the management of pituitary adenomas. Pituitary 16:419–434

    Article  Google Scholar 

  14. Zhou Y, Zhang X, Klibanski A (2013) Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma. Mol Cell Endocrinol. doi:10.1016/j.mce.2013.09.006

  15. Suhardja AS, Kovacs KT, Rutka JT (1999) Molecular pathogenesis of pituitary adenomas: a review. Acta Neurochir (Wien) 141:729–736

    Article  CAS  Google Scholar 

  16. Nag A, Bagchi S, Raychaudhuri P (2004) Cul4A physically associates with MDM2 and participates in the proteolysis of p53. Cancer Res 64:8152–8155

    Article  CAS  PubMed  Google Scholar 

  17. Lu X, Guo J, Hsieh TC (2003) PC-SPES inhibits cell proliferation by modulating p21, cyclins D, E and B and multiple cell cycle-related genes in prostate cancer cells. Cell Cycle 2:59–63

    Article  CAS  PubMed  Google Scholar 

  18. Higa LA, Banks D, Wu M, Kobayashi R, Sun H, Zhang H (2006) L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle 5:1675–1680

    Article  CAS  PubMed  Google Scholar 

  19. Li B, Jia N, Kapur R, Chun KT (2006) Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis. Blood 107:4291–4299

    Article  CAS  PubMed  Google Scholar 

  20. Jiang L, Rong R, Sheikh MS, Huang Y (2011) Cullin-4A.DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis. J Biol Chem 286:6971–6978

    Article  CAS  PubMed  Google Scholar 

  21. Gejman R, Swearingen B, Hedley-Whyte ET (2008) Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum Pathol 39:758–766

    Article  CAS  PubMed  Google Scholar 

  22. Botelho CH, Magalhaes AV, Mello PA, Schmitt FC, Casulari LA (2006) Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas. Arq Neuropsiquiatr 64:60–66

    Article  PubMed  Google Scholar 

  23. Banks D, Wu M, Higa LA, Gavrilova N, Quan J, Ye T, Kobayashi R, Sun H, Zhang H (2006) L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes. Cell Cycle 5:1719–1729

    Article  CAS  PubMed  Google Scholar 

  24. McCutcheon IE (2013) Pituitary adenomas: surgery and radiotherapy in the age of molecular diagnostics and pathology. Curr Probl Cancer 37:6–37

    Article  PubMed  Google Scholar 

  25. Huh J, Piwnica-Worms H (2013) CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol 33:213–226

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Lee J, Zhou P (2012) Pathogenic role of the CRL4 ubiquitin ligase in human disease. Front Oncol 2:21

    PubMed Central  PubMed  Google Scholar 

  27. Schindl M, Gnant M, Schoppmann SF, Horvat R, Birner P (2007) Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. Anticancer Res 27:949–952

    CAS  PubMed  Google Scholar 

  28. Waning DL, Li B, Jia N, Naaldijk Y, Goebel WS, HogenEsch H, Chun KT (2008) Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis. Blood 112:320–329

    Article  CAS  PubMed  Google Scholar 

  29. Bondar T, Kalinina A, Khair L, Kopanja D, Nag A, Bagchi S, Raychaudhuri P (2006) Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome. Mol Cell Biol 26:2531–2539

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Higa LA, Yang X, Zheng J, Banks D, Wu M, Ghosh P, Sun H, Zhang H (2006) Involvement of CUL4 ubiquitin E3 ligases in regulating CDK inhibitors Dacapo/p27Kip1 and cyclin E degradation. Cell Cycle 5:71–77

    Article  CAS  PubMed  Google Scholar 

  31. Zemmoura I, Wierinckx A, Vasiljevic A, Jan M, Trouillas J, Francois P (2012) Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management. Pituitary 16:515–522

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by National Natural Science Foundation of China No. 81172528, 31271461, Doctoral Fund of Ministry of Education of China No. 20110131110035, Natural Science Foundation of Shandong Province No. ZR2011HM034 and Taishan Scholar Program of Shandong Province (GW).

Conflict of interest

None of the authors has any conflict of interest associated with the present work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guangwei Wei.

Additional information

Yangyang Xu and Yunshan Wang are joint first authors.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, Y., Wang, Y., Ma, G. et al. CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation. J Neurooncol 116, 625–632 (2014). https://doi.org/10.1007/s11060-013-1349-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-013-1349-2

Keywords

Navigation